
NeoGenix Biosciences is an innovative biotechnology company focused on modernizing fertility treatments worldwide. Founded in 2019, they develop user-centered technologies for sperm selection, gamete handling, AI-based gamete detection, and fertilization. Their solutions, including SpermGuide and SpermSearch AI, leverage microfluidics and AI to improve IVF laboratory workflows by reducing processing time and error rates. SpermGuide mimics natural selection processes to isolate high-quality sperm, preserving DNA integrity, while SpermSearch AI enhances the speed and accuracy of sperm identification in complex samples. The company aims to empower IVF technicians and embryologists, ultimately improving patient outcomes.

NeoGenix Biosciences is an innovative biotechnology company focused on modernizing fertility treatments worldwide. Founded in 2019, they develop user-centered technologies for sperm selection, gamete handling, AI-based gamete detection, and fertilization. Their solutions, including SpermGuide and SpermSearch AI, leverage microfluidics and AI to improve IVF laboratory workflows by reducing processing time and error rates. SpermGuide mimics natural selection processes to isolate high-quality sperm, preserving DNA integrity, while SpermSearch AI enhances the speed and accuracy of sperm identification in complex samples. The company aims to empower IVF technicians and embryologists, ultimately improving patient outcomes.